Carl-Hendrik Heldin

Carl-Hendrik Heldin

Chairman at
European Molecular Biology Organization
72 year
Miscellaneous
Consumer Services
Health Technology

Profile

Carl-Hendrik Heldin is the founder of Mesenkia Therapeutics AB. Current jobs include Chairman at the European Molecular Biology Organization since 2016, Chairman at Science for Life Laboratory since 2013, and Professor at the University of Uppsala since 1992.
Former jobs include Chairman at The Nobel Foundation from 2013 to 2024, Director at Ludwig Institute for Cancer Research Ltd. (Sweden) from 1986 to 2017, Independent Director at Kancera AB from 2012 to 2025, and Vice President at the European Research Council.

Carl-Hendrik Heldin active positions

CompaniesPositionStart
Corporate Officer/Principal 01/01/1992
Chairman 01/01/2013
European Molecular Biology Organization
Chairman 01/01/2016

Former positions of Carl-Hendrik Heldin

CompaniesPositionEnd
KANCERA AB Director/Board Member 26/05/2025
Chairman 02/12/2024
Ludwig Institute for Cancer Research Ltd. (Sweden)
Director/Board Member 01/01/2017
Corporate Officer/Principal 01/01/2014
See the detail of Carl-Hendrik Heldin's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

87

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Services

Miscellaneous

European Molecular Biology Organization

Miscellaneous

Health Technology

Ludwig Institute for Cancer Research Ltd. (Sweden)

Commercial Services

  1. Stock Market
  2. Insiders
  3. Carl-Hendrik Heldin